Cargando…
Somatic mutations as markers of outcome after azacitidine and allogeneic stem cell transplantation in higher-risk myelodysplastic syndromes
Autores principales: | , , , , , , , , , , , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Nature Publishing Group UK
2018
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6462855/ https://www.ncbi.nlm.nih.gov/pubmed/30291338 http://dx.doi.org/10.1038/s41375-018-0284-9 |
_version_ | 1783410649359974400 |
---|---|
author | Falconi, Giulia Fabiani, Emiliano Piciocchi, Alfonso Criscuolo, Marianna Fianchi, Luana Lindfors Rossi, Elisa L. Finelli, Carlo Cerqui, Elisa Ottone, Tiziana Molteni, Alfredo Parma, Matteo Santarone, Stella Candoni, Anna Sica, Simona Leone, Giuseppe Lo-Coco, Francesco Voso, Maria Teresa |
author_facet | Falconi, Giulia Fabiani, Emiliano Piciocchi, Alfonso Criscuolo, Marianna Fianchi, Luana Lindfors Rossi, Elisa L. Finelli, Carlo Cerqui, Elisa Ottone, Tiziana Molteni, Alfredo Parma, Matteo Santarone, Stella Candoni, Anna Sica, Simona Leone, Giuseppe Lo-Coco, Francesco Voso, Maria Teresa |
author_sort | Falconi, Giulia |
collection | PubMed |
description | |
format | Online Article Text |
id | pubmed-6462855 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2018 |
publisher | Nature Publishing Group UK |
record_format | MEDLINE/PubMed |
spelling | pubmed-64628552019-06-25 Somatic mutations as markers of outcome after azacitidine and allogeneic stem cell transplantation in higher-risk myelodysplastic syndromes Falconi, Giulia Fabiani, Emiliano Piciocchi, Alfonso Criscuolo, Marianna Fianchi, Luana Lindfors Rossi, Elisa L. Finelli, Carlo Cerqui, Elisa Ottone, Tiziana Molteni, Alfredo Parma, Matteo Santarone, Stella Candoni, Anna Sica, Simona Leone, Giuseppe Lo-Coco, Francesco Voso, Maria Teresa Leukemia Brief Communication Nature Publishing Group UK 2018-10-05 2019 /pmc/articles/PMC6462855/ /pubmed/30291338 http://dx.doi.org/10.1038/s41375-018-0284-9 Text en © The Author(s) 2018 Open Access This article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons license, and indicate if changes were made. The images or other third party material in this article are included in the article’s Creative Commons license, unless indicated otherwise in a credit line to the material. If material is not included in the article’s Creative Commons license and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this license, visit http://creativecommons.org/licenses/by/4.0/. |
spellingShingle | Brief Communication Falconi, Giulia Fabiani, Emiliano Piciocchi, Alfonso Criscuolo, Marianna Fianchi, Luana Lindfors Rossi, Elisa L. Finelli, Carlo Cerqui, Elisa Ottone, Tiziana Molteni, Alfredo Parma, Matteo Santarone, Stella Candoni, Anna Sica, Simona Leone, Giuseppe Lo-Coco, Francesco Voso, Maria Teresa Somatic mutations as markers of outcome after azacitidine and allogeneic stem cell transplantation in higher-risk myelodysplastic syndromes |
title | Somatic mutations as markers of outcome after azacitidine and allogeneic stem cell transplantation in higher-risk myelodysplastic syndromes |
title_full | Somatic mutations as markers of outcome after azacitidine and allogeneic stem cell transplantation in higher-risk myelodysplastic syndromes |
title_fullStr | Somatic mutations as markers of outcome after azacitidine and allogeneic stem cell transplantation in higher-risk myelodysplastic syndromes |
title_full_unstemmed | Somatic mutations as markers of outcome after azacitidine and allogeneic stem cell transplantation in higher-risk myelodysplastic syndromes |
title_short | Somatic mutations as markers of outcome after azacitidine and allogeneic stem cell transplantation in higher-risk myelodysplastic syndromes |
title_sort | somatic mutations as markers of outcome after azacitidine and allogeneic stem cell transplantation in higher-risk myelodysplastic syndromes |
topic | Brief Communication |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6462855/ https://www.ncbi.nlm.nih.gov/pubmed/30291338 http://dx.doi.org/10.1038/s41375-018-0284-9 |
work_keys_str_mv | AT falconigiulia somaticmutationsasmarkersofoutcomeafterazacitidineandallogeneicstemcelltransplantationinhigherriskmyelodysplasticsyndromes AT fabianiemiliano somaticmutationsasmarkersofoutcomeafterazacitidineandallogeneicstemcelltransplantationinhigherriskmyelodysplasticsyndromes AT piciocchialfonso somaticmutationsasmarkersofoutcomeafterazacitidineandallogeneicstemcelltransplantationinhigherriskmyelodysplasticsyndromes AT criscuolomarianna somaticmutationsasmarkersofoutcomeafterazacitidineandallogeneicstemcelltransplantationinhigherriskmyelodysplasticsyndromes AT fianchiluana somaticmutationsasmarkersofoutcomeafterazacitidineandallogeneicstemcelltransplantationinhigherriskmyelodysplasticsyndromes AT lindforsrossielisal somaticmutationsasmarkersofoutcomeafterazacitidineandallogeneicstemcelltransplantationinhigherriskmyelodysplasticsyndromes AT finellicarlo somaticmutationsasmarkersofoutcomeafterazacitidineandallogeneicstemcelltransplantationinhigherriskmyelodysplasticsyndromes AT cerquielisa somaticmutationsasmarkersofoutcomeafterazacitidineandallogeneicstemcelltransplantationinhigherriskmyelodysplasticsyndromes AT ottonetiziana somaticmutationsasmarkersofoutcomeafterazacitidineandallogeneicstemcelltransplantationinhigherriskmyelodysplasticsyndromes AT moltenialfredo somaticmutationsasmarkersofoutcomeafterazacitidineandallogeneicstemcelltransplantationinhigherriskmyelodysplasticsyndromes AT parmamatteo somaticmutationsasmarkersofoutcomeafterazacitidineandallogeneicstemcelltransplantationinhigherriskmyelodysplasticsyndromes AT santaronestella somaticmutationsasmarkersofoutcomeafterazacitidineandallogeneicstemcelltransplantationinhigherriskmyelodysplasticsyndromes AT candonianna somaticmutationsasmarkersofoutcomeafterazacitidineandallogeneicstemcelltransplantationinhigherriskmyelodysplasticsyndromes AT sicasimona somaticmutationsasmarkersofoutcomeafterazacitidineandallogeneicstemcelltransplantationinhigherriskmyelodysplasticsyndromes AT leonegiuseppe somaticmutationsasmarkersofoutcomeafterazacitidineandallogeneicstemcelltransplantationinhigherriskmyelodysplasticsyndromes AT lococofrancesco somaticmutationsasmarkersofoutcomeafterazacitidineandallogeneicstemcelltransplantationinhigherriskmyelodysplasticsyndromes AT vosomariateresa somaticmutationsasmarkersofoutcomeafterazacitidineandallogeneicstemcelltransplantationinhigherriskmyelodysplasticsyndromes |